regorafenib
bayer
[]
the #oncoalerttoptweet for day1 #gi23 tweet a positive trial in later line #gastroesophageal is always an accomplishment integrate iia meets primary os endpoint best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨